Summary & Overview
HCPCS G8873: Needle Localization Specimen Verification
HCPCS Level II code G8873 represents intraoperative verification services for needle localization specimens that cannot be confirmed with intraoperative imaging. This code applies to scenarios such as MRI needle wire localization or targets seen on mammogram or ultrasound that lack an implanted biopsy marker but can be confirmed by direct inspection or pathology. Nationally, the code captures a specific set of surgical localization activities important for accurate excision and pathology correlation in breast procedures.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for G8873, the typical surgical setting where the service is performed, and what to expect in payer coverage discussions. The publication outlines benchmarks and common billing considerations, highlights relevant policy updates affecting intraoperative verification services, and summarizes clinical scenarios in which the code is typically applied. Data limitations are noted where input fields were not provided.
Billing Code Overview
HCPCS Level II code G8873 describes services for patients with needle localization specimens that are not amenable to intraoperative imaging. Examples include MRI needle wire localization and targets identified on mammogram or ultrasound that do not contain a biopsy marker but can be verified on intraoperative inspection or pathology (for example, a needle biopsy site where the biopsy marker is remote from the actual biopsy site).
-
Service type: Localization and intraoperative verification of non-imaged needle biopsy targets
-
Typical site of service: Surgical suite or operating room where breast surgical procedures and specimen verification occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient is referred for surgical excision of a suspicious breast lesion that was previously localized with a needle-wire or clip marker but where the marker does not accurately represent the actual biopsy site on intraoperative imaging. For example, a patient with a diagnostic mammogram demonstrating a subtle architectural distortion and a prior percutaneous needle biopsy whose marker is remote from the true target. The breast surgeon schedules an operative localization and excision under general anesthesia in an ambulatory surgical center or hospital operating room. Intraoperative inspection and specimen radiography or pathology verification are used to confirm removal of the lesion when standard intraoperative imaging (such as MRI-guided localization) is not possible or the target is not amenable to intraoperative imaging.
Clinical workflow:
-
Preoperative review of imaging (mammography, ultrasound) by the surgeon and radiologist to plan needle localization.
-
Preoperative or intraoperative localization using needle-wire or skin marking as appropriate; documentation that the target may not be verifiable by intraoperative imaging.
-
Excision of the localized specimen in the operating room with specimen orientation and submission for intraoperative pathology (frozen section) or postoperative permanent section.
-
Specimen radiography or pathologic correlation performed when feasible; surgeon documents verification of target by intraoperative inspection or final pathology when imaging verification is not possible.
Typical site of service: Hospital outpatient operating room or Ambulatory Surgery Center for breast surgical excision when intraoperative imaging is not feasible.